[144] Crown Castle Inc. SEC Filing
Crown Castle's Form 144 notifies the market of a proposed sale of 15,000 common shares through Charles Schwab & Co., Inc. with an aggregate market value of $1,586,924.00. The filing shows the shares represent a tiny fraction of the company's capital structure — 15,000 of 435,470,061 outstanding shares — and lists the intended sale date as 08/08/2025 on the NYSE.
The shares were acquired on 02/19/2019 through a restricted/performance stock lapse from Crown Castle Inc., with the consideration noted as equity compensation. The filer attests they are unaware of any undisclosed material adverse information and reports no securities sold in the past three months.
- Full disclosure of proposed sale: includes number of shares (15,000), aggregate value ($1,586,924.00), broker (Charles Schwab & Co.) and planned sale date (08/08/2025).
- Clear acquisition history: shares acquired on 02/19/2019 via restricted/performance stock lapse from Crown Castle Inc., paid as equity compensation.
- None.
Insights
TL;DR: Routine insider sale notice of 15,000 shares (~$1.59M), immaterial relative to outstanding shares.
The Form 144 is a standard regulatory disclosure documenting a proposed sale via a broker and provides useful granularity: number of shares, aggregate value, planned sale date, acquisition method and original acquisition date. The size of the proposed sale (15,000 shares) is approximately 0.0034% of the reported outstanding shares, indicating the transaction is immaterial to overall equity supply and unlikely to move the market by itself. The filing also confirms no reported sales in the prior three months, which helps establish recent insider activity.
TL;DR: Disclosure aligns with Rule 144 requirements and includes an attestation about material information.
The document meets key compliance elements: identification of broker, class and quantity of securities, acquisition details (restricted/performance lapse on 02/19/2019), and representation that the filer knows of no undisclosed material adverse information. From a governance perspective, this transparency supports market oversight; the small size relative to outstanding shares suggests limited governance or control implications.